MedAlliance announces enrollment of First Patient in SELUTION SLR LOVE-DEB Coronary Study

The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease treated with SELUTION SLR™. This is a trial initiated by physicians at the Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust, which is where the first patient was enrolled. SELUTION SLR is a novel sirolimus-eluting balloon that provides […]

thaipr.net

11 ก.ย. 66

PeproMene Bio, Inc. Announced Completion of the First Dose Cohort and Opening of the Second Dose Cohort in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells)

PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the first dose cohort of its phase 1 relapsed or refractory B-cell Non-Hodgkin Lymphoma (r/r B-NHL) clinical trial of PMB-CT01 (BAFFR-CAR T Cells) has been completed. No Dose Limiting Toxicity (DLT) was observed, and the study […]

thaipr.net

11 ก.ย. 66

Microland and Serco AsPac Announce Strategic Partnership to Drive Digital Transformation

The partnership will focus on providing exceptional digital public services, enabling business growth, delivering enhanced digital experience, and accelerating cloud adoption. Microland Limited and Serco AsPac, a division of Serco Group, one of the world’s largest providers of public services, today announced a strategic partnership to drive digital transformation leveraging cloud for business agility and […]

thaipr.net

11 ก.ย. 66
1 1,237 1,238 1,239 1,240 1,241 3,308